Delivery Order SPE2DB20D3101-SPE2DB24FQVB8
Award Date
11/21/23
Potential Completion Date
11/22/23
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,080.29 delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialized medication used for diabetes management. The contract has a firm fixed price pricing type and a period of performance through November 25, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order valued at $16,689.04. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply the government with VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of July 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,966.32 delivery order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used to treat diabetes. The contract has an ultimate completion date of August 31, 2022 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,914.72 delivery order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medical product used for diabetes management. The contract has an ultimate completion date of June 30, 2022 and is a firm fixed-price agreement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,472.01 Firm Fixed Price delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of July 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $8,655.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialty diabetes medication. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,426.63 Firm Fixed Price Delivery Order covers the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used for diabetes management. The contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $12,461.42, is a delivery order for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a medication used in the treatment of diabetes. The contract has a firm fixed price structure and an ultimate completion date of September 10, 2024. AmerisourceBergen, as the prime contractor, will be responsible for...
This federal contract award, valued at $5,213.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication for diabetes management. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued up to $999,999,999.00 and runs through...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,437.62, is a delivery order for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. The contract has an ultimate completion date of May 30, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...